1. Corporate Officers - S
2. Smith Karen L.

Insider Trading History of Smith Karen L.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Smith Karen L. since 2016. This trader's CIK number is 1639637. At the time of last reporting, Smith Karen L. was the Director of Aurinia Pharmaceuticals Inc.. (stock ticker symbol AUPH). Also see all insider trading activities at Aurinia Pharmaceuticals Inc..

Note that in the past Smith Karen L. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ) by Smith Karen L.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	JAZZ	1,745	$250,044	0	$0	0	$0

Yearly summary of insider trading at Aurinia Pharmaceuticals Inc. (AUPH) by Smith Karen L.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	AUPH	0	$0	5,241	$44,181	17,913	$0

Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Smith Karen L.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	XLRN	0	$0	20,789	$2,885,922	17,850	$773,314

Insider trading activities at 3 companies by Smith Karen L.:

1. Jazz Pharmaceuticals Plc (JAZZ)

2. Aurinia Pharmaceuticals Inc. (AUPH)

3. Acceleron Pharma Inc (XLRN)

Table 1. Insider trading of Jazz Pharmaceuticals Plc (JAZZ) by Smith Karen L.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-08-12	JAZZ	Buy	608	137.18	83,406
2016-07-13	JAZZ	Buy	580	143.63	83,304
2016-06-13	JAZZ	Buy	557	149.61	83,334

Table 2. Insider trading of Aurinia Pharmaceuticals Inc. (AUPH) by Smith Karen L.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-11-08	AUPH	Option Ex	17,913	.00	0
2024-11-11	AUPH	Sale	5,241	8.43	44,181

Table 3. Insider trading of Acceleron Pharma Inc (XLRN) by Smith Karen L.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-04-05	XLRN	Sale	11,864	140.64	1,668,552
2021-04-05	XLRN	Option Ex	8,925	43.32	386,657
2021-04-01	XLRN	Sale	8,925	136.40	1,217,370
2021-04-01	XLRN	Option Ex	8,925	43.32	386,657

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Karen L. (Director of Aurinia Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month